![]() |
市场调查报告书
商品编码
1764959
亚太饲料抗球虫药市场预测(至2031年)-区域分析-按类型(离子载体抗球虫药、化学抗球虫药和化学离子载体抗球虫药)、剂型(干粉和液体抗球虫药)和牲畜(家禽、反刍动物、猪和其他)划分Asia Pacific Feed Anticoccidials Market Forecast to 2031 - Regional Analysis - by Type (Ionophore, Chemical Anticoccidials, and Chemical-Ionophores), Form (Dry and Liquid), and Livestock (Poultry, Ruminants, Swine, and Others) |
2023 年亚太饲料抗球虫药市值为 4.8272 亿美元,预计到 2031 年将达到 6.5092 亿美元;预计 2023 年至 2031 年的复合年增长率为 3.8%。
非离子载体药物在动物饲料的应用推动了亚太地区饲料抗球虫药市场的发展
离子载体具有一定程度的抗菌活性,符合抗生素的传统定义。所有离子载体均已获准用于肉鸡生产,但并非所有离子载体均获准或安全地用于火鸡。盐霉素和甲基萘甲霉素对火鸡和马科动物具有相当大的毒性。由于离子载体属于抗生素,因此不应连续使用,而应与其他抗球虫药物轮换使用。此外,抗生素作为饲料添加剂在饲料中的使用受到严格监管。因此,生产商正在开发各种不能被称为抗生素的抗球虫药。
非离子载体药物是经由化学合成的化合物,因此属于化学抗球虫药。它们透过杀灭活性消灭球虫,或透过抑制活性抑制球虫。它们没有已知的抗菌活性,因此不被视为抗生素。非离子载体药物含有尼卡巴嗪、唑来林、氨丙啉、氯吡醇、癸氧喹酯、罗贝尼定和地克珠利。 EW Nutrition 是一家农业综合企业,致力于提供可靠的解决方案,减少抗生素需求,尤其是在饲料中,该公司已开发出用于动物饲料的非离子载体药物。鑑于所有这些因素,担心在动物饲料中使用抗生素的畜牧养殖户可以选择非离子载体抗球虫药。因此,在预测期内,非离子载体药物在动物饲料中的引入预计将为饲料抗球虫药市场带来丰厚的利润。
亚太饲料抗球虫药市场概况
中国是最大的猪肉和家禽生产国之一,制定了有效的防治措施,以控制球虫等影响动物健康和生长速度的疾病。集约化养殖场球虫病的发生使得使用饲料抗球虫药物对于减少经济损失至关重要。这些损失是由于受感染动物的饲料转换效率下降、增重降低和死亡率上升所造成的。
中国政府高度重视食品安全和品质,推动了饲料抗球虫药市场的发展。农业农村部等监管机构对兽药和饲料添加剂的使用制定了严格的指导方针,以确保抗球虫产品的安全性和有效性。此外,在中国,天然和非化学抗球虫药的使用也呈现成长趋势。
亚太地区饲料抗球虫药市场收入及预测(2031年)(百万美元)
亚太饲料抗球虫药市场细分
亚太地区饲料抗球虫药市场根据其种类、剂型、牲畜和国家进行细分。根据类型,亚太地区饲料抗球虫药市场可细分为离子载体类、化学抗球虫药和化学离子载体类。 2023年,离子载体类占了最大的市场。
从剂型来看,亚太地区饲料抗球虫药市场分为干粉剂型和液体剂型。 2023年,干粉剂型就占了更大的市场。
亚太地区饲料抗球虫药市场依牲畜细分,可分为家禽、反刍动物、猪及其他动物。 2023年,家禽类饲料占最大市场。
根据国家/地区,亚太地区饲料抗球虫药市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2023年,中国占据了亚太地区饲料抗球虫药市场的主导地位。
Phibro Animal Health Corp、Zoetis Inc、Kemin Industries Inc、Elanco Animal Health Inc、Innovista Feeding Solutions Pvt Ltd、Huvepharma EOOD、Impextraco NV、Virbac SA.、International Animal Health Products Pty Ltd 和 Zamira Australia Ltd. 是亚太地区饲料抗球虫药市场的一些领先企业。
The Asia Pacific feed anticoccidials market was valued at US$ 482.72 million in 2023 and is expected to reach US$ 650.92 million by 2031; it is estimated to record a CAGR of 3.8% from 2023 to 2031.
Introduction of Non-Ionophores in Animal Feed Boosts Asia Pacific Feed Anticoccidials Market
Ionophores have some degree of antibacterial activity and fit the classical definition of an antibiotic. All ionophores are approved for broiler chicken production, but not all are approved or safe for turkeys. Salinomycin and narasin are quite toxic for turkeys and equines. As ionophores are antibiotics, they should not be used continuously but instead rotated with different anticoccidials. Moreover, there are stringent regulations on using antibiotics in feed as an additive. Thus, manufacturers are developing different anticoccidials that cannot be called antibiotics.
Non-ionophores are compounds produced by chemical synthesis; thus, they fall under the category of chemical anticoccidials. They destroy coccidia by cidal activity or suppress coccidia by static activity. They have no known antibacterial activity; hence, they are not considered as an antibiotic. Non-ionophores are products containing nicarbazin, zoalene, amprolium, clopidol, decoquinate, robenidine and diclazuril. EW Nutrition-an agribusiness company that creates solutions that bring reliable benefits with reduced need for antibiotics, especially in feed-has developed non-ionophores for animal feed. Owing to all these factors, livestock farmers concerned about using antibiotics in animal feed can opt for non-ionophore anticoccidials. Therefore, the introduction of non-ionophore in animal feed is expected to offer lucrative opportunities for the feed anticoccidials market during the forecast period.
Asia Pacific Feed Anticoccidials Market Overview
China is one the largest producers of pork and poultry, creating effective control measures for diseases such as coccidia, which can impact animal health and growth rates. The occurrence of coccidiosis in intensive farming operations makes the adoption of feed anticoccidials crucial in mitigating economic losses. These losses are generated from decreased feed conversion efficiency, lower weight gain, and increased mortality rates among the infected animals.
The government of China focuses on food safety and quality, which propels the market for feed anticoccidials. Regulatory bodies such as the Ministry of Agriculture and Rural Affairs (MARA) have stringent guidelines for the use of veterinary drugs and feed additives, ensuring the safety and efficacy of anticoccidial products. Furthermore, there is a growing trend of the use of natural and nonchemical anticoccidials in China.
Asia Pacific Feed Anticoccidials Market Revenue and Forecast to 2031 (US$ Million)
Asia Pacific Feed Anticoccidials Market Segmentation
The Asia Pacific feed anticoccidials market is segmented based on type, form, livestock, and country. Based on type, the Asia Pacific feed anticoccidials market is segmented into ionophore, chemical anticoccidials, and chemical-ionophores. The ionophore segment held the largest market share in 2023.
In terms of form, the Asia Pacific feed anticoccidials market is bifurcated into dry and liquid. The dry segment held a larger market share in 2023.
Based on livestock, the Asia Pacific feed anticoccidials market is segmented into poultry, ruminants, swine, and others. The poultry segment held the largest market share in 2023.
Based on country, the Asia Pacific feed anticoccidials market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific feed anticoccidials market share in 2023.
Phibro Animal Health Corp, Zoetis Inc, Kemin Industries Inc, Elanco Animal Health Inc, Innovista Feeding Solutions Pvt Ltd, Huvepharma EOOD, Impextraco NV, Virbac SA., International Animal Health Products Pty Ltd, and Zamira Australia Ltd. are some of the leading players operating in the Asia Pacific feed anticoccidials market.